|
|
|
Volumn 13, Issue 11, 2010, Pages 762-764
|
|
European respiratory society (ERS) - 20th annual congress
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
[4 [2 (3 FLUORO 4 TRIFLUOROMETHYLPHENYL) 4 METHYL 5 THIAZOLYLMETHYLTHIO] 2 METHYLPHENOXY]ACETIC ACID;
ANTIASTHMATIC AGENT;
AZD 9668;
BENRALIZUMAB;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
BIW 8405;
CHEMOKINE RECEPTOR CXCR2 ANTAGONIST;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
FORMOTEROL;
FORMOTEROL FUMARATE;
GW 642444;
INDACATEROL;
INTERLEUKIN 5 RECEPTOR;
IPRATROPIUM BROMIDE;
KHK 4563;
LAS 100977;
LEUKOCYTE ELASTASE;
OC 000459;
PF 3429281;
PLACEBO;
SALMETEROL;
SALMETEROL XINAFOATE;
SCH 527123;
SELEXIPAG;
TIOTROPIUM BROMIDE;
UNCLASSIFIED DRUG;
AREA UNDER THE CURVE;
ASTHMA;
BRONCHIECTASIS;
BRONCHOSPASM;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CONFERENCE PAPER;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG ACTIVITY;
DRUG BLOOD LEVEL;
DRUG DOSE TITRATION;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG POTENCY;
DRUG RECEPTOR BINDING;
DRUG SAFETY;
DRUG STRUCTURE;
ENZYME INHIBITION;
EOSINOPHIL COUNT;
FORCED EXPIRATORY VOLUME;
HUMAN;
INFLAMMATORY CELL;
LUNG RESISTANCE;
LUNG VASCULAR RESISTANCE;
MEDICAL SOCIETY;
NONHUMAN;
PREMEDICATION;
PULMONARY HYPERTENSION;
QUALITY OF LIFE;
RHINOPHARYNGITIS;
SINGLE DRUG DOSE;
SPUTUM;
TREATMENT RESPONSE;
UNSPECIFIED SIDE EFFECT;
UPPER RESPIRATORY TRACT INFECTION;
ANIMALS;
ASTHMA;
DRUG DELIVERY SYSTEMS;
DRUG DESIGN;
DRUGS, INVESTIGATIONAL;
HUMANS;
HYPERTENSION, PULMONARY;
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;
RESPIRATORY TRACT DISEASES;
|
|
EID: 78650262460
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (3)
|
|
References (0)
|
